Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Sera Prognostics, Inc.

Market Cap 73.23M 63.25M 58.28M 54.55M 102M 6.96B 104M 688M 268M 3.39B 275M 269M 11.73B P/E Ratio 2026 *
-2.85x
P/E Ratio 2027 * -3.34x
Enterprise Value 73.23M 63.25M 58.28M 54.55M 102M 6.96B 104M 688M 268M 3.39B 275M 269M 11.73B EV / Sales 2026 *
202x
EV / Sales 2027 * 27.4x
Free-Float
86.29%
Yield 2026 *
-
Yield 2027 * -
1 day-3.11%
1 week-18.34%
Current month-13.43%
1 month+17.61%
3 months-12.21%
6 months-46.72%
Current year-36.61%
1 week 1.86
Extreme 1.86
2.31
1 month 1.59
Extreme 1.59
2.37
Current year 1.56
Extreme 1.56
3.85
1 year 1.56
Extreme 1.56
4.09
3 years 1.37
Extreme 1.37
12.36
5 years 1.1
Extreme 1.1
15.5
10 years 1.1
Extreme 1.1
15.5
Manager TitleAgeSince
Chief Executive Officer 52 2023-05-14
Director of Finance/CFO 39 2023-06-06
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 74 2011-04-19
Chairman 59 2023-06-07
Director/Board Member 59 2011-10-31
Date Insider Type Main position Quantity % Market Cap.
06-08Sell

Chief Executive Officer

-20,755 0.0543%
06-08Sell

Chief Financial Officer

-5,440 0.0142%
06-07Sell

Director

-1,560 0.0041%
Change 5-day change 1-year change 3-year change Capi.($)
-3.11%-18.34%+9.36%-45.48% 73.23M
+0.63%+0.02%+5.74%+4.31% 22.24B
-2.41%0.00%+37.01% - 19.54B
+0.22%-3.00%+20.54%-26.32% 3.44B
-2.06%-15.31%+59.18%+7.70% 2.9B
+1.59%-8.64%-21.96%-33.00% 2.09B
+1.44%+0.95%-24.26% - 1.88B
-1.00%-1.54%+158.88%+161.98% 1.87B
+9.24%+0.17%+181.11%+266.60% 1.69B
+1.28%-8.40%+5.31%-9.31% 1.58B
Average +0.58%-3.01%+43.09%+40.81% 5.73B
Weighted average by Cap. -0.29%-1.58%+28.15%+19.30%

Financials

2026 *2027 *
Net sales 362K 313K 289K 270K 506K 34.46M 514K 3.41M 1.33M 16.77M 1.36M 1.33M 58.07M 2.68M 2.31M 2.13M 1.99M 3.73M 254M 3.79M 25.14M 9.8M 124M 10.04M 9.83M 429M
Net income -33.26M -28.73M -26.47M -24.78M -46.44M -3.16B -47.16M -313M -122M -1.54B -125M -122M -5.33B -29.98M -25.89M -23.86M -22.33M -41.86M -2.85B -42.5M -282M -110M -1.39B -113M -110M -4.8B
Net Debt - -
Logo Sera Prognostics, Inc.
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Employees
72
Date Price Change Volume
26-06-12 1.870 $ -3.11% 49,966
26-06-11 1.930 $ -3.50% 51,420
26-06-10 2.000 $ -6.10% 99,259
26-06-09 2.130 $ +1.43% 57,678
26-06-08 2.100 $ -8.30% 36,381
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.870USD
Average target price
5.500USD
Spread / Average Target
+194.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SERA Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!